Companies: 10,795·Total market cap: $144.5T
NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc.

NRXPNASDAQHealthcare● Active
$4.33
+$0.19(+4.59%)
Market Cap$74847142
P/E Ratio
52W High$5.055
52W Low$1.62
Overview

NRx Pharmaceuticals, Inc. (NRXP) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · NRXP · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.28nrxp eps ttm · nrxp earnings per shareEarnings history
PE Ratio (TTM)nrxp pe ratio ttm · nrxp price to earningsPE Ratio deep dive
Revenue (TTM)$2.3Mnrxp revenue ttm · nrxp annual revenueFull revenue history
Dividend YieldNo Dividenddoes nrxp pay dividends · nrxp dividend yieldDividend history
Shares Outstanding21.4Mnrxp shares outstanding · nrxp floatShares outstanding history
Next EarningsAug 17, 2026Est.nrxp earnings date · nrxp next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$1.2M
202320242025
nrx pharmaceuticals, inc. revenue · nrxp revenue 2025
FY 2025Net Income-$28.6M▼ 13.91% YoY
202320242025
nrx pharmaceuticals, inc. net income · nrxp profit 2025
FY 2025EPS$-1.34▲ +43.93% YoY
202320242025
nrxp eps · nrx pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $2.3MNet Income: -$24.5MEPS: $-1.28View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis nrxp a buy · nrxp analyst rating
Strong Buy
0
Buy
5
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$2.00Low
$4.33Current
$2.00Avg Target53.81% downside
$2.00High
nrxp price target · nrxp 12 month forecast

Total: 5 · Buy rate: 100.0%

The NRXP analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $2.00, representing -53.81% downside from the current price of $4.33.

Stock Performance

Full History
1D+4.59%
1W+19.94%
1M+40.58%
3M+154.71%
YTD+59.78%
1Y+17.98%
5Y-97.47%

About NRx Pharmaceuticals, Inc.

CEOJonathan C. Javitt
IPO DateDec 4, 2017
Employees2
CountryUS

NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for disorders of the central nervous system and critical lung diseases. Its product port…

what is nrx pharmaceuticals, inc. · nrxp stock overview · nrx pharmaceuticals, inc. company profile · who is nrx pharmaceuticals, inc. ceo · nrxp NASDAQ · nrx pharmaceuticals, inc. headquarters · nrx pharmaceuticals, inc. business segments

About Stock Overview & Key Data

NRx Pharmaceuticals, Inc. (NRXP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 4, 2017. As of the latest trading session, NRXP stock price is $4.33, with a market capitalization of $74.8M. The stock has returned +17.98% over the past 12 months and +59.78% year-to-date.

According to 5 Wall Street analysts, the consensus rating for NRx Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $2.00. In fiscal year 2025, NRx Pharmaceuticals, Inc. reported revenue of $1.2M and net income of -$28.6M. For detailed data — including NRx Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, NRx Pharmaceuticals, Inc. (NRXP) stock price is $4.33. The stock is traded on NASDAQ under the ticker symbol NRXP. The 52-week range is $1.62 – $5.05.

NRXP stock priceNRXP quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice